Business Description

Description
Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage product under the following name: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate and breast cancer indications, AR-42 is provided for hematological malignancies and solid tumors indications and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -40
12-1 Month Momentum % -97.14

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials

ARNI's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ARNI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Arno Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.43
Beta 0.6
Volatility % 99.89
14-Day RSI 0
14-Day ATR ($) 0.000007
20-Day SMA ($) 0.00006
12-1 Month Momentum % -97.14
52-Week Range ($) 0.00006 - 0.0021
Shares Outstanding (Mil) 49.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arno Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Arno Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Arno Therapeutics Inc Frequently Asked Questions

What is Arno Therapeutics Inc(ARNI)'s stock price today?
The current price of ARNI is $0.00. The 52 week high of ARNI is $0.00 and 52 week low is $0.00.
When is next earnings date of Arno Therapeutics Inc(ARNI)?
The next earnings date of Arno Therapeutics Inc(ARNI) is .
Does Arno Therapeutics Inc(ARNI) pay dividends? If so, how much?
Arno Therapeutics Inc(ARNI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1